| |
|
|
| |
| 投稿时间： 2015-08-24 最后修改时间： 2015-10-21 摘要点击次数: 3688 全文下载次数: 6 |
| |
| 引用本文：郭志刚, 洪冬喆, 刘伊,等.我国基本药物集中采购量价挂钩实施影响因素分析[J].中国卫生政策研究,2015,8(12):1-6 |
|
| 郭志刚1, 洪冬喆1, 刘伊1, 郭娜1, 王宝敏2, 韩晟2, 史录文1,2, 管晓东1,2 |
1. 北京大学药学院 北京 100191;
2. 北京大学医药管理国际研究中心 北京 100191 |
| 基金项目:国家自然科学基金青年科学基金(71303011) |
| |
|
| | 摘要:目的:为完善我国基本药物集中采购工作和量价挂钩政策提供建议。方法:搜集基本药物集中招标采购文件和文献,结合文献研究和半结构化访谈法设计调研问卷。通过问卷调研和电话访谈,分析我国基本药物集中采购中量价挂钩政策实施相关影响因素。结果:量价挂钩定义需明确药品的剂型和规格,其主要影响因素有:采购区域范围、采购的药品类别、疾病与药品替代性、采购方式、采购周期、回款时间和结算方式、采购过程中的违规行为。建议:实施量价挂钩,需明确预测采购数量的主体和方式、营造量价挂钩价格合理形成的政策环境,取消药品中标价联动机制,严格执行回款期限、统一结算方式,加强省级药品采购平台的信息化建设,并做好部分药品量价挂钩试点工作,为量价挂钩的推广奠定基础。 | |
|
|
关键词:基本药物 集中采购 量价挂钩 带量采购
|
| |
| Influencing factors of quantity-based pricing in the essential medicines' centralized bidding procurement in China |
| GUO Zhi-gang1, HONG Dong-zhe1, LIU Yi1, GUO Na1, WANG Bao-min2, HAN Sheng2, SHI Lu-wen1,2, GUAN Xiao-dong1,2 |
1. School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
2. International Research Center of Medicinal Administration, Peking University, Beijing 100191, China |
| |
|
| | Abstract:Objective: The paper aims to provide recommendations for improving the essential medicines' centralized bidding procurement and quantity-based pricing policy. Methods: Based on the documents and literature on essential medicines' centralized bidding procurement, we analyzed the factors which have a great impact on implementation of the quantity-based pricing in essential medicines' centralized procurement using the text research, semi-structured interview questionnaire and on-phone interviews. Results: The quantity-based pricing needs to define a generic name and specific dosage form of drugs in the essential medicines' centralized procurement. Its implementation was mainly influenced by the following factors: the procurement area accessibility, the pharmaceuticals category, disease and drug alternative procurement methods and cycle, the payment and settlement time, and irregularities in the procurement process. Suggestions: During this implementation, we also need to clearly predict the quantity and procurement method, set up a proper policy environment for a quantity-based pricing, cancel the price linkage mechanism, strictly put into practice the payment deadline, employ a unique billing method and strengthen the information construction for the provincial centralized procurement platform. Some medicines' quantity-based pricing should be carried out in the chosen pilots for laying a good foundation for its promotion. | |
|
|
|
|
